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INTRODUCTION
Cell motility, such as smooth muscle contraction and cell migration, is
controlled by the reversible phosphorylation of the regulatory light chain of myosin II
and other cytoskeletal proteins. Mounting evidence suggests that in smooth muscle cells
and other types of cells in vertebrates, myosin phosphatase (MP) plays an important role
in controlling the phosphorylation of myosin II as well as other cytoskeletal proteins,
including ezrin, moesin, and radixin.1 MP is a holoenzyme consisting of a catalytic
subunit of a type-1 Ser/Thr phosphatase (PP1C) delta isoform, a myosin phosphatase
targeting subunit 1 (MYPT1), and an accessory subunit M21. In this ternary complex,
MYPT1 is responsible for regulating the phosphatase activity.1
A recent X-ray crystallographic study revealed an allosteric interaction
between PP1C and the N-terminal ankyrin repeat domain of MYPT1 that confers the
substrate specificity of the enzyme.2 MP activity is suppressed when Thr696 or Thr853 of
MYPT1 is phosphorylated by various kinases, such as ROCK, ZIPK, ILK, and PAK.1,3
However, it is still unclear how the phosphorylation of MYPT1 inhibits MP activity.
The amino acid sequence around Thr696 of MYPT1 is highly conserved among MYPT1
family members including MYPT2 and MBS85. Therefore, structural insights into the
inhibitory domain of MYPT1 are expected to provide new clues to fully elucidate the
mechanism that controls phosphatase activity via the phosphorylation of MYPT1 or
other family members involved in kinase-phosphatase crosstalk in cytoskeletal
regulation.
Here,

we prepared

a bacterial

recombinant fragment of MYPT1

corresponding to residues 658 to 714, including the phosphorylation site Thr696, and
determined its three-dimensional structure through the use of computer-assisted distance

geometry and a simulated annealing protocol combined with stable-isotope-aided
multi-dimensional NMR techniques.

MATERIALS AND METHODS
Molecular cloning and NMR sample preparation
Protein preparation was performed using a previously reported method.4
Briefly, the cDNA fragment encoding the 57-residue peptide corresponding to residues
658 to 714 of human MYPT1 was cloned into a modified pET30 vector that produces
His x6 fusion protein with a PreScission protease recognition site.5 The protein was
uniformly labeled with 15N or doubly labeled with 15N and 13C by over-expression in E.
coli grown in minimal media containing

15

NH4Cl and/or

13

C-glucose. Purification was

carried out using a chelating His-tag column. The fused tag was cleaved using
PreScission protease during dialysis in the buffer for the NMR sample. The protein
includes three extra amino acid residues Gly-Pro-Met at the N-terminus.
NMR spectroscopy
The NMR samples consisted of ~1 mM protein, 20 mM sodium phosphate,
100 mM sodium chloride, and 0.03 % NaN3. The solvent contained 10 or 100 % D2O
for NMR locking, and the pH of the solution was measured directly with a pH meter
and adjusted to 6.0. All NMR experiments were performed on a Varian INOVA 750
MHz spectrometer with a 5 mm 1H{13C/15N} triple-resonance probe containing a Z-axis
gradient coil.6 During the NMR experiments, the sample temperature was maintained at
10.0 °C. For backbone resonance assignments, we recorded 1H-15N HSQC, HNCA,
CBCA(CO)NH, and HNCACB spectra.7 To assign the resonances of the side chains,
C(CO)NH, H(CCO)NH,
recorded.

7,8

15

N-edited TOCSY, and HCCH-TOCSY spectra were

To obtain distance information, we measured 15N-edited NOESY, 13C-edited

NOESY, and

1

H-1H 2D-NOESY spectra.7,8 Homonuclear 2D-NOESY,

13

C-edited

NOESY, and HCCH-TOCSY were obtained with the sample dissolved in D2O. All NOE
experiments were acquired using a 150 ms mixing time. The NMR data were processed
and displayed by NMRPipe.9 The processed NMR spectra were displayed and analyzed
by Sparky.10

Structural calculation
A total of 527 independent unambiguous NOE peaks were selected and used
as inputs in the calculation of the structure together with 86 TALOS dihedral angle
restraints.11 Additionally, 62 hydrogen bond restraints based on the secondary structure
were used in the calculation. The calculation was executed using the simulated
annealing protocol sa.inp in XPLOR-NIH version 2.050.12 The 20 lowest energy
structures were selected from the final calculations for 100 structures. The 20 structures
had no distance or angle violations. The quality of the structures was analyzed by
Procheck-NMR.13 The structures were also displayed and analyzed by MOLMOL.14

RESULTS AND DISCUSSION
Previous reports have shown that the thiophosphorylated MYPT1 C-terminal
fragment and the MBS85 fragment including the inhibitory phosphorylation site inhibit
isolated PP1C activity.4,5 Indeed, our preliminary study suggests that when the
57-residue MYPT1 fragment containing Thr696 (MYPT1(658-714)) is phosphorylated, it
inhibits the activity of MP purified from smooth muscle cells as well as the activity of
the enzyme associated with cytoskeletons in skinned smooth muscle fibers.5 The amino
acid sequence is shown in Figure 1(A).
We prepared the NMR-active stable-isotope-labeled peptide of this fragment,
MYPT1(658-714), by using an Escherichia coli over-expression system. The uniformly
15

N- and doubly

13

C/15N-labeled peptides were subjected to a series of NMR

experiments that are described in the Materials and Methods section. The 1H-15N HSQC
spectra were acquired at various temperatures (10, 15, 20, 25, and 30 °C) and pH values
(4.4, 5.8, and 7.3) in order to optimize the conditions. At 10 °C and pH 6.0,
MYPT1(658-714) displayed 1H-15N HSQC spectra with excellent cross-peak dispersion,
as shown in Figure 1(B). The number of peaks as well as their intensities and line
shapes suggest that MYPT1(658-714) exists in a single conformation under these
conditions, and as a result, all NMR measurements were performed under these
optimized conditions.
The detailed procedures used for resonance assignment and structural

calculation are described in the Materials and Methods section. Extensive NMR data
analysis resulted in resonance assignments for all of the 1HN, 1Hα,

13

Cα, and

15

N

1

resonances in the peptide backbone and for more than 95 % of the H resonances of the
side chains. Finally, 527 NOE peaks, 62 hydrogen bonds, and 86 angle constraints were
employed in the structural calculation. Figure 1(C) shows overlaid images of the 20
lowest energy models obtained from the structural calculation. Statistics describing
these 20 structures are shown in Table 1. The stereo-chemical quality of the structures
was analyzed by the Procheck-NMR method. In total, 97.0 % of all amino acid residues
were found in either the fully allowed or partially allowed region of the Ramachandran
plot.
As shown at the bottom of Figure 1(C), the average structure of
MYPT1(658-714) is relatively extended and consists of three helices. The helices
correspond to residues 658-668 (helix A), 673-696 (helix B), and 703-710 (helix C).
The structure of each helical region is well converged among the 20 models with
backbone RMSD values of 0.35 +/- 0.09 (helix A), 0.86 +/- 0.22 (helix B), and 0.33 +/0.10 Å (helix C). Helices A and B, and helices B and C are connected by short loop
regions corresponding to residues 669-673 and 697-701, respectively. The short loop
comprising residues 669-673 that connects helices A and B contains a Pro residue at
position 672. The resonance of Pro672 13Cγ appears at relatively low field, 27.4 ppm, and
the peaks of Thr671 and Val673 are sharp and clear in the 1H-15N HSQC plot (Figure 1(B)).
Moreover, the NOE cross peaks of the α1H of Thr671 and the two protons in the
δ position of Pro672 were detected in the
Figure 2. Hence, we concluded that Pro

13

672

C-edited NOESY spectrum, as shown in

is in the trans conformation and not in a

17,18

cis-trans equilibrium state.

The orientation of the three helices was not defined in this structural study. As
shown in Table 1, few long-range NOE signals were observed and were insufficient to
determine the overall structure. One possibility of such an ill-defined structure is that
the lack of long-range NOE signals is due to the extended molecular shape. Another
possibility is that the two loop regions have a degree of flexibility that prevents the
convergence of the solution structure. To address this issue, residual dipolar coupling
constants (RDCs) can provide useful information.19 Thus, we attempted to prepare
samples for these NMR experiments. However, this was unsuccessful due to unexpected
interactions between the MYPT1 fragment and the co-solute, pf1-phage. Therefore,

another approach, {1H}-15N heteronuclear NOE spectroscopy, was used to obtain
information about the dynamics

(Figure 3).20 The loop regions show relatively small

values of the peak intensity ratio (NOEon / NOEoff) compared to the three helical regions,
which indicates the existence of higher flexibility in the loop regions. Thus, the overall
structure of MYPT1(658-714) is variable due to the flexibility of the inter-helical angle.
The phosphorylation site Thr696 is located at the C-terminal end of helix B.
The structural plasticity of the loop region connecting helix B and C is possibly required
for recognition by kinases, such as ROCK, ZIPK, ILK, and PAK. The helical structure
of the MYPT1 inhibitory domain is similar to the structure of the autoinhibitory
mechanism of calcineurin (CaN).21 As shown in the crystal structure of the inactive
form of CaN without calmodulin, the α-helical autoinhibitory domain directly docks at
the active site of CaN.22 Thus, it is possible that the flexibility of the loop structure of
MYPT1(658-714) detected in this work provides accessibility to the catalytic center of
MP. Figure 4 illustrates the hypothetical surface structure colored by electrostatic
potential. Importantly, positively charged residues including Arg682, Arg687, and Arg690
are present in helix B, and hydrophobic side chains including Val699, Leu701, and Leu704
are clustered in helix C. As predicted from the crystal structure of the MP catalytic
domain,2 these basic and hydrophobic regions have the potential to form
complementary interactions with the acidic and hydrophobic grooves of the active site
of MP. However, no information regarding the local structure around the Thr696
phosphorylation site was obtained. Nonetheless, it is possible that the flexibility of the
inter-helical angle of the MYPT1(658-714) fragment in solution is analogous to the
motion of the intact MP at the phosphorylation site. The present NMR structural study
of the model peptide revealed residues that potentially play important roles in the
phosphorylation of Thr696 and in the inhibition of MP that is necessary for cytoskeletal
regulation in cells. Further functional and structural studies of intact MP with full-length
MYPT1 as well as a study on a fragment of MYPT1 including Thr853 are currently
being undertaken by our group.

Coordinates of the 20 structures and resonance assignments were deposited in PDB
(2kjy) and BMRB (16346), respectively.
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FIGURE LEGENDS
Figure 1. Overview of MYPT1(658-714) solution structure. (A) Amino acid
sequence of MYPT1(658-714). (B) 1H-15N HSQC spectrum of MYPT1(658-714).
Each peak is labeled with amino acid type and residue number. Phosphorylation site,
Thr696, is labeled with red letters. Signals from the tag sequence at the N-terminus are
labeled with asterisk. (C) Backbone traces of the 20 lowest energy structures
obtained via structural calculation. From top to bottom, three structures drawn as
wire models are superimposed on helices A, B, and C. The ribbon model is depicted
using an averaged and energy-minimized coordinate. Only the Thr696 side chain is
illustrated as a ball-and-stick model. Starting and ending residues of helices are
labeled with amino acid type and residue number. (D) {1H}-15N heteronuclear NOE
results plotted versus residue numbers of MYPT1(658-714). Orange bars indicate
helical regions. (E) Surface potential of MYPT1(658-714). Blue and red indicate
positively and negatively charged areas, respectively.

SUPPLIMENTARY MATERIALS
Figure S1. Strip plot of
671

Thr

13

C-edited NOESY of MYPT1(658-714). Alpha proton of

has NOEs with delta protons of Pro672, suggesting that Pro672 is in the trans

conformation.

Table 1. Summary of restraints and statistics of the final 20 structures of
MYPT1(658-714).
RMSD to the mean structure (Å)
Region

T659 - S668

R674 - T696

T702 - T709

Backbone

0.35 + 0.09

0.86 + 0.22

0.33 + 0.10

All heavy atoms

1.64 + 0.14

1.82 + 0.22

1.30 + 0.20

Unambiguous restraints
Intraresidue NOEs

235

Sequential NOEs

177

Medium-range NOEs (1 < |i - j| < 4)

113

Long-range NOEs (|i - j| > 5)

2

Hydrogen bond restraints

62

TALOS angle restraints

86

Total number of structural restraints

675

Experimental restraint violations
Distances with violations > 0.3 Å

0

Dihedral angles with violations > 5 Å

0

X-PLOR energy terms (kcal/mol)

Eoverall

96.5985 + 1.1496

Ebonds

4.4920 + 0.1677

Eangles

69.2550 + 0.6868

Eimproper

2.2584 + 0.9245

Evdw

10.1468 + 1.3369

Enoe

0.3381 + 0.0741

Ecdih

10.1093 + 0.1743

Figure 1

Figure S1

